Stephanie Venn-Watson, Co-Founder and CEO

Professional Overview

Stephanie Venn-Watson is a seasoned biotech entrepreneur and industry leader with expertise in translational medicine, research program development, and innovative therapeutic solutions. As the Co-Founder and CEO of Seraphina Therapeutics and Epitracker, Inc., she is spearheading the advancement of novel therapies and technologies to address critical unmet medical needs.

Experience Summary

Current Role

As the Co-Founder and CEO of Seraphina Therapeutics, Stephanie is leading the development of innovative therapeutics derived from marine-based fatty acids. Under her guidance, the company has made significant strides in advancing its pipeline and forging strategic partnerships to bring its novel solutions to the market. Concurrently, she serves as the Co-Founder and CEO of Epitracker, Inc., a company focused on developing transformative technologies to improve disease detection and monitoring.

Career Progression

Prior to her entrepreneurial endeavors, Stephanie held various leadership roles at prestigious organizations, including the National Marine Mammal Foundation, the Defense Advanced Research Projects Agency (DARPA), and the Centers for Disease Control and Prevention (CDC). As the Director of the Translational Medicine & Research Program at the National Marine Mammal Foundation, she spearheaded groundbreaking research on the application of marine-derived compounds in human and animal health. Her experience as a Technical Agent at DARPA's Defense Sciences Office and her roles at the CDC, where she led the Global Salmonella Surveillance Program and the National Center for Emerging and Zoonotic Infectious Diseases, have equipped her with a deep understanding of translational research, public health challenges, and the development of innovative solutions.

Academic Background

Stephanie holds a Bachelor of Science degree from the University of Georgia, where she specialized in Microbiology and Public Health. Her academic achievements and multidisciplinary background have been instrumental in shaping her career trajectory and enabling her to tackle complex scientific and public health challenges.

Areas of Expertise

Stephanie's areas of expertise include translational medicine, research program development, biotechnology innovation, public-private partnerships, and strategic leadership. She has a proven track record of successfully navigating the dynamic biotech landscape, identifying unmet needs, and developing transformative solutions that have a tangible impact on human and animal health.

Professional Impact

Throughout her career, Stephanie has made significant contributions to the advancement of marine-derived therapeutics, the enhancement of disease surveillance and monitoring systems, and the promotion of interdisciplinary collaboration between the public and private sectors. Her work has been recognized within the industry, and she is a sought-after speaker and thought leader in the field of biotech innovation.

Conclusion

Stephanie Venn-Watson's diverse experience, scientific expertise, and entrepreneurial spirit have positioned her as a trailblazer in the biotech industry. As the Co-Founder and CEO of Seraphina Therapeutics and Epitracker, Inc., she is poised to continue driving innovation and delivering impactful solutions that address critical healthcare challenges.